| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Research Abstract |
Antithrombin III (AT-III), an anticoagulant, has recently been reported to directly affect human platelet functions. However, the exact mechanism of AT-III in platelets remains to be clarified. Our results strongly suggest that AT-III directly acts on platelets and suppresses ADP-induced platelet granule secretion such as platelet-derived growth factor-AB and serotonin due to inhibiting HSP27 phosphorylation via p44/p42 mitogen-activated protein (MAP) kinase and p38 MAP kinase.
|
